Scioto Biosciences, Inc. Announces Top-Line Results of SB-121 in a Phase Ib Trial in Patients Diagnosed With Autism Spectrum Disorder

In a fireside chat, Jim Bullard and Toph Day unpack interest rates, productivity, and regional competitiveness. Their insight helps founders navigate uncertainty and plan strategically for a higher-rate, innovation-driven economy.

Myles Grote offers a clear view into today’s recalibrated venture landscape, where investors prioritize evidence, resilience, and market clarity. Indiana founders gain practical guidance for fundraising in a selective but opportunity-rich environment.

Mike Langellier breaks down shifting SaaS performance trends, emphasizing efficiency, retention, and early AI adoption. Founders learn what “good” looks like in 2026 and how disciplined growth shapes investor confidence.